We noticed you are on our UK page. Want to switch regions? Choose from the options:

Alt
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Oncology_Headshot_GA_Dr-Luis-Aznar-Garcia.jpeg

Dr Luis Aznar-Garcia

Dr Luis Aznar-Garcia
MD, PhD, MRCR Consultant Clinical Oncologist

Languages spoken

English, Spanish

Expert in

Brain and Spine cancer, Breast cancer, Lung cancer

Overview

Centres

Nottingham
Nottingham

The Park Centre for oncology, Sherwood Lodge Drive, Burntstump Country Park, Nottingham, NG5 8RX

53.050498950912186, -1.1434615981524467
/uk/our-centres/nottingham

Specialises in

Brain and spine cancer
Condition
Condition/Cancer
Condition/Cancer/Brain and spine cancer
Breast Cancer
Condition
Condition/Cancer
Condition/Cancer/Breast cancer
Lung Cancer
Condition
Condition/Cancer
Condition/Cancer/Lung cancer

Treatments

MR linac
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/MR Linac
MRIdian
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/MRIdian
Stereotactic ablative radiotherapy (SABR)
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Stereotactic ablative radiotherapy
Stereotactic radiosurgery (SRS)
Service
Service/Cancer
Service/Cancer/Radiotherapy
Service/Cancer/Radiotherapy/Stereotactic radiosurgery

Special clinical interests in Brain Metastases SRS, SABR for Oligometastasis any site and any primary, Hepatobilliary cancers (HpB) and Breast cancer.

Dr Luis Aznar-Garcia is currently working as a Consultant Clinical Oncologist at the Nottingham University Hospitals as Stereotactic Radiosurgery (SRS) and Brain Metastases MDT Lead Clinician. He is involved in Stereotactic Ablative Radiotherapy (SABR/SBRT) for Oligometastases, Hepatobilliary (HpB) tumours and breast cancer.

Dr Luis Aznar-Garcia has broad experience in the field of high advanced radiotherapy treatments. His main expertise is in the area of the Stereotactic Radiotherapy (SRS and SABR/SBRT), with vast professional experience using Gammknife, Cyberknife, Magnetic Resonance Image Guided Radiotherapy (MRL) and Linac-based platforms to treat metastatic disease as well as primary tumours. He has treated with Stereotactic techniques more than 1000 patients since 2001.

Dr Luis Aznar-Garcia has been Head of Radiotherapy Department at Leicester University Hospitals for 3 years and Head of Radiotherapy and Radiosurgery at Ruber International Hospital (Madrid, Spain) for 2 years. He has been a Clinical Oncologist Consultant for more than 20 years.

Dr Luis Aznar-Garcia is Honorary (Consultant) Assistant Professor at University of Nottingham.

He is a member of multiple National and International Oncological Societies (ESTRO, ISRS, ESMO, RCR, SEOR…).

Dr Luis Aznar-Garcia is Editor of several International Oncological Journals. He has published around 37 papers in International Medical Journals, books and meeting presentations.

Dr Luis Aznar-Garcia is Investigator in several Stereotactic Radiotherapy Trials (CORE, ABC-07, OligoRare, SARON, HALT, SPARC, SCALOP 2), some of them as Principal Investigator.

In addition, he has had a successful application to Genome England Clinical Interpretation Partnership (GeCIP).

Career positions

Current position(s)

  • Consultant Clinical Oncologist at the Nottingham University Hospitals

Past position(s)

  • Head of Radiotherapy Department at Leicester University Hospitals for 3 years
  • Head of Radiotherapy and Radiosurgery at Ruber International Hospital (Madrid, Spain) for 2 years
  • He has been a Clinical Oncologist Consultant for more than 20 years.

Expertise and interests

Expertise

  • Stereotactic Radiotherapy (SRS and SABR/SBRT)

Professional association

  • Member of the Royal College of Physicians (MRCP)
  • Member of International Society of Stereotactic Radiosurgery (ISRS)